Furthermore, the phenotype observed in APT121;p19Arf−/− mice is consistent with that reported in a prior study on APT121;p53−/− mice [35], confirming the importance of p19Arf-Mdm2-p53 signaling in tumor suppression of APT121-induced prostate cancer. This evidence concerns the gene MDM2 and prostate carcinoma.